Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Area of Science:

• Immunology
• Biochemistry
• Cancer Research

Background:

• Reactive oxygen species (ROS) are vital mediators in immune responses, including innate and adaptive immunity.
• Modulating ROS levels presents a promising strategy for enhancing anticancer immunity.
• Understanding the multifaceted roles of ROS, which vary by concentration, location, and microenvironment, is crucial.

Purpose of the Study:

• To review the diverse effects of ROS on key components of the anticancer immune response.
• To evaluate the potential and challenges of targeting ROS in cancer immunotherapy.
• To highlight the need for advanced technologies for precise ROS modulation.

Main Methods:

• Literature review of studies investigating ROS effects on macrophage polarization.
• Analysis of ROS impact on immune checkpoint blocking (ICB) therapy efficacy.
• Examination of ROS roles in T cell activation, expansion, and immunogenic cell death induction.

Main Results:

• ROS exhibit pleiotropic effects, often detrimental, but not always amenable to simple scavenging.
• ROS generally have undesirable effects on T cell activation and expansion.
• Current evidence indicates a complex, context-dependent role for ROS in cancer immunity.

Conclusions:

• A comprehensive understanding of ROS's dual functions is essential for successful clinical application.
• Advanced technologies for spatiotemporal and species-specific ROS tuning are necessary.
• Integrating ROS-targeted therapies with existing immunotherapies holds significant potential for improving cancer treatment efficacy.